WHO to take final decision next week on approval to Bharat Biotech’s Covaxin
New Delhi: The WHO will take a call on granting Emergency Use Listing (EUL) status for Bharat Biotech's COVID-19 vaccine ...
Read moreNew Delhi: The WHO will take a call on granting Emergency Use Listing (EUL) status for Bharat Biotech's COVID-19 vaccine ...
Read moreNew Delhi: The World Health Organisation’s (WHO) approval for the indigenous Covid-19 vaccine Covaxin, developed by Hyderabad-based Bharat Biotech, is ...
Read moreNew Delhi: The first nasal vaccine against Covid-19 has been developed by Bharat Biotech. It has received regulator's nod for ...
Read moreGeneva: A top vaccines official at the World Health Organisation says the agency expects to make a decision next month ...
Read moreHyderabad: Bharat Biotech’s Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus. This data about ...
Read moreNew Delhi: India will miss a target to administer over a half billion Covid-19 vaccine doses by the end of ...
Read moreHyderabad: Bharat Biotech said Friday it terminated the Memorandum of Understanding (MoU) entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C ...
Read moreNew Delhi: Health Minister Mansukh Mandaviya said Tuesday several Indian companies are increasing their production of Covid-19 vaccine production. Mansukh ...
Read moreHyderabad: Ocugen Inc., Bharat Biotech's partner for USA and Canada for Covid-19 vaccine Covaxin has initiated a rolling submission to ...
Read moreNew Delhi: Bharat Biotech said Monday it has submitted all documents required for the emergency use listing (EUL) of its ...
Read more